Innogenetics N.V.
Patent Owner
Stats
- 46 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jul 04, 2013 most recent publication
Details
- 46 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,651 Total Citation Count
- Mar 23, 1990 Earliest Filing
- 126 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
7422848 Hepatitis-B viral variants with reduced susceptibility to nucleoside analogs and uses thereofMar 15, 06Sep 09, 08[C12Q]
7255997 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agentsAug 15, 00Aug 14, 07[G01N]
7195765 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agentsJul 06, 01Mar 27, 07[A61K]
7196183 Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agentAug 29, 02Mar 27, 07[C07H]
7157226 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agentsApr 27, 94Jan 02, 07[C12Q]
7129337 Sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agentsOct 23, 95Oct 31, 06[C07H]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0171,656 DETECTION, IDENTIFICATION AND DIFFERENTIATION OF PROTEUS SPECIES USING THE SPACER REGIONAbandonedMar 06, 13Jul 04, 13[C12Q]
8343493 Antibodies specific of the β-amyloid peptides and their uses as diagnostic agents or drugsExpiredOct 24, 08Jan 01, 13[A61K, C12P, C12N, G01N, C07K]
8163873 Isolated microtubule-associated protein tau peptides and kitExpiredNov 10, 08Apr 24, 12[A61K]
2011/0136,678 METHODOLOGY FOR ANALYSIS OF SEQUENCE VARIATIONS WITHIN THE HCV NS3/4A GENOMIC REGIONAbandonedOct 19, 07Jun 09, 11[C12Q, C12P, C12N, C40B]
2011/0020,803 MARKERS FOR THE PROGNOSIS OF LUNG FUNCTION AND COLONIZATION WITH AN INFECTIOUS AGENTAbandonedSep 29, 08Jan 27, 11[C12Q]
7855052 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agentsExpiredNov 30, 06Dec 21, 10[C07H, C12Q, C12P, C12N]
2009/0325,145 METHODOLOGY FOR ANALYSIS OF SEQUENCE VARIATIONS WITHIN THE HCV NS5B GENOMIC REGIONAbandonedOct 19, 07Dec 31, 09[C12Q, C12P, C12N]
2009/0191,558 DETECTION, IDENTIFICATION AND DIFFERENTIATION OF SERRATIA SPECIES USING THE SPACER REGIONAbandonedDec 09, 08Jul 30, 09[C07H, C12Q, G01N]
2009/0098,558 DETECTION, IDENTIFICATION AND DIFFERENTIATION OF PROTEUS SPECIES USING THE SPACER REGIONAbandonedOct 16, 08Apr 16, 09[C12Q, C12N]
2009/0068,651 Method for the detection of the antibiotic resistance spectrum of mycobacterium speciesAbandonedJun 27, 07Mar 12, 09[C07H, C12Q]
2009/0017,456 DETECTION, IDENTIFICATION AND DIFFERENTIATION OF EUBACTERIAL TAXA USING A HYBRIDIZATION ASSAYAbandonedMar 10, 08Jan 15, 09[C07H, C12Q]
2008/0274,144 HCV E1 COMPRISING SPECIFIC DISULFIDE BRIDGESAbandonedMar 24, 08Nov 06, 08[A61K, C12N, G01N, A61P, C07K]
7390623 Detection and identification of staphylococcus aureus and epidermidis using the 16S-23S rRNA spacerExpiredJul 21, 04Jun 24, 08[C12Q]
2008/0138,894 PURIFIED HEPATITIS C VIRUS ENVELOPE PROTEINS FOR DIAGNOSTIC AND THERAPEUTIC USEAbandonedFeb 23, 07Jun 12, 08[C12N]
2008/0131,888 Nucleic Acid Variants in the Ficolin Genes Associated with Altered Innate ImmunityAbandonedJan 20, 06Jun 05, 08[C07H, C12Q]
7279170 32-kDa protein derived from Mycobacterium tuberculosis and related peptidesExpiredJun 22, 06Oct 09, 07[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.